(Q34830170)

4 August 2017

1 reference

title

Nucleic acid amplification technology methods used in blood donor screening (English)

1 reference

4 August 2017

Grant PR

1

1 reference

4 August 2017

Busch MP

series ordinal

2

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

12

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

229-242

1 reference

Genetic disease detection and DNA amplification using cloned thermostable ligase

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Impact of specimen handling and storage on detection of hepatitis C virus RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Experiences in HCV-NAT screening prior to releasing cellular components by the German Red Cross Blood Transfusion Service of Baden-Württemberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Development of multiplexed nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Nucleic acid sequence-based amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Characteristics and applications of nucleic acid sequence-based amplification (NASBA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Gammagard and reported hepatitis C virus episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Automated screening of blood donations for hepatitis C virus RNA using the Qiagen BioRobot 9604 and the Roche COBAS HCV Amplicor assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

A novel RT-PCR for reliable and rapid HCV RNA screening of blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Detection of hepatitis B virus sequences in serum by using in vitro enzymatic amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Allelic discrimination by nick-translation PCR with fluorogenic probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Sensitive detection of genetic variants of HIV-1 and HCV with an HIV-1/HCV assay based on transcription-mediated amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Simultaneous detection of multiple nucleic acid targets in a homogeneous format

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

The risks of infection transmission by blood transfusion in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

NAT of the United States and Canadian blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Evaluation of a new HTLV-I/II polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Advances in nucleic acid-based detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

The ligation amplification reaction (LAR)--amplification of specific DNA sequences using sequential rounds of template-dependent ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

Performance characteristics of the AmpliScreen HIV-1 test, an assay designed for screening plasma mini-pools

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3148.2002.00382.X

10.1046/J.1365-3148.2002.00382.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference